SZELA MARY T (CEO and President) purchased 2.2% of their position (9.54K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $50.3K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 1/29/2025ACC: 0001415889-25-002292
DirectorOfficer· CEO and President
Since Feb 2026
+289.54K
Net shares
Net buyer
$50.3K
Total acquired
2
Open market trades
2B · 0S
4
Total transactions
289.54K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+40K
Price / share
—
Trade value
—
% of position
10.4%
1/27/2025
384.68K→424.68K
Common Stock
Direct
Shares
+4.83K
Price / share
$5.42
Trade value
$26.16K
% of position
1.1%
1/27/2025
424.68K→429.50K
Common Stock
Direct
Shares
+4.72K
Price / share
$5.12
Trade value
$24.15K
% of position
1.1%
1/28/2025
429.50K→434.22K
Total
Net shares
+49.54K
Net value
$50.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2025 | A · Award | +40K | — | — | 10.4% | 384.68K | 424.68K |
| Common Stock Direct | 1/27/2025 | P · Purchase | +4.83K | $5.42 | $26.16K | 1.1% | 424.68K | 429.50K |
| Common Stock Direct | 1/28/2025 | P · Purchase | +4.72K | $5.12 | $24.15K | 1.1% | 429.50K | 434.22K |
| Total | +49.54K | $50.30K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
240K shares
Shares
+240K
Strike price
5.30
Held after
240K
Exercisable
—
1/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock240K shares | 1/27/2025 | A · Award | +240K | 5.30 | — | 240K |